Skip to main content

Pfizer claims 3rd dose 'strongly' boosts protection against Delta variant

Share

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.

The data posted online, which are expected to be discussed in a company earnings call on Wednesday morning, suggest that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose.

Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.

There's "estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three," researchers wrote in the Pfizer data slides.

The data have not yet been peer-reviewed or published.

The data also show that antibody levels are much higher after a third dose than a second dose against the original coronavirus variant and the Beta variant, first identified in South Africa.

CTVNews.ca Top Stories

MPs targeted by Chinese hackers question why Canada didn't tell them

Members of Parliament are questioning why Canadian security officials did not inform them that they had been the target of Beijing-linked hackers, after learning from the FBI that the international parliamentary alliance they are a part of was in the crosshairs of the Chinese cyberattack in 2021.

WATCH

WATCH So you haven't filed your taxes yet…

The clock is ticking ahead of the deadline to file a 2023 income tax return. A personal finance expert explains why you should get them done -- even if you owe more than you can pay.

Local Spotlight

Stay Connected